Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), Copenhagen, Denmark; Laboratory for Molecular Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Danish National Research Foundation Centre for Cardiac Arrhythmia (DARC), Copenhagen, Denmark; Laboratory for Molecular Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Can J Cardiol. 2017 May;33(5):674-681. doi: 10.1016/j.cjca.2017.02.015. Epub 2017 Mar 6.
Because of ambiguous reports in the literature, we aimed to investigate the association between PR interval and the risk of all-cause and cardiovascular death, heart failure, and pacemaker implantation, allowing for a nonlinear relationship.
We included 293,111 individuals, corresponding to one-third of the population in the greater region of Copenhagen. These individuals had a digital electrocardiogram recorded in a general practitioner's core facility from 2001-2011. Data on drug use, comorbidities, and outcomes were collected from Danish registries. We divided the population into 7 groups based on the population PR interval distribution. Cox models were used, with reference to a PR interval between 152 and 161 ms (40th to < 60th percentile).
During follow-up, we identified 34,783 deaths from all causes, 9867 cardiovascular deaths, 9526 cases of incident heart failure, and 1805 pacemaker implantations. A short PR interval (< 125 ms; hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.08-1.41; P = 0.001) as well as a long PR interval (> 200 ms; HR, 1.23; 95% CI, 1.14-1.32; P < 0.001) was associated with an increased risk of cardiovascular death after multivariable adjustment. A long PR interval conferred an increased risk of heart failure (> 200 ms; HR, 1.31; 95% CI, 1.22-1.42; P < 0.001). An increasing PR interval conferred an increased risk of pacemaker implantation, in a dose-response manner, with the highest risk associated with a PR interval > 200 ms (HR, 3.49; 95% CI, 2.96-4.11; P < 0.001).
PR interval was significantly associated with the risk of the adverse outcomes investigated. The nonlinear relationships, in combination with relatively weak associations, could contribute to previously reported conflicting results on the subject.
由于文献中的报告存在歧义,我们旨在研究 PR 间期与全因和心血管死亡、心力衰竭和起搏器植入的风险之间的关联,并允许存在非线性关系。
我们纳入了 293111 名个体,这些个体对应于哥本哈根大都市区人口的三分之一。这些个体在 2001-2011 年间在全科医生核心设施中记录了数字心电图。使用来自丹麦登记处的数据收集药物使用、合并症和结局信息。我们根据人群 PR 间期分布将人群分为 7 组。使用 Cox 模型,参考 PR 间期在 152 至 161ms 之间(第 40 至<60 百分位数)。
在随访期间,我们确定了 34783 例全因死亡、9867 例心血管死亡、9526 例新发心力衰竭病例和 1805 例起搏器植入。短 PR 间期(<125ms;风险比[HR],1.23;95%置信区间[CI],1.08-1.41;P=0.001)和长 PR 间期(>200ms;HR,1.23;95%CI,1.14-1.32;P<0.001)与多变量调整后的心血管死亡风险增加相关。长 PR 间期(>200ms;HR,1.31;95%CI,1.22-1.42;P<0.001)与心力衰竭风险增加相关。PR 间期的增加与起搏器植入的风险呈剂量反应关系,最高风险与 PR 间期>200ms 相关(HR,3.49;95%CI,2.96-4.11;P<0.001)。
PR 间期与研究中不良结局的风险显著相关。非线性关系与相对较弱的关联相结合,可能导致以前关于该主题的报告结果相互矛盾。